Summary & Overview
CPT 78070: Parathyroid Dual-Tracer Imaging with Subtraction
CPT code 78070 represents a specialized nuclear medicine procedure used to image the parathyroid glands using two different radiopharmaceuticals and image-comparison or subtraction techniques to localize abnormal tissue. This procedure is clinically important for the evaluation and preoperative localization of hyperfunctioning parathyroid tissue, which can guide surgical planning and affect patient outcomes. Nationally, accurate coding and coverage determination for this specialized imaging study influence access to diagnostic workups for primary and secondary hyperparathyroidism.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the code, typical sites of service, and common billing modifiers. The publication summarizes payer coverage patterns and reimbursement benchmarks where available, highlights relevant clinical context for ordering clinicians and coding staff, and notes policy trends that affect authorization and documentation requirements. Where input data are incomplete, the report clearly indicates missing items. The content is aimed at billing managers, radiology and nuclear medicine departments, and policy analysts seeking a compact reference on CPT code 78070.
Billing Code Overview
CPT code 78070 describes a nuclear medicine parathyroid imaging study in which the provider acquires two sets of images after administering very small amounts of two different radiopharmaceuticals or radioactive tracers. The images are compared and often normalized or subtracted from one another to highlight abnormal parathyroid tissue.
-
Service type: Diagnostic nuclear medicine imaging with dual-tracer comparison and potential subtraction technique
-
Typical site of service: Outpatient imaging center or hospital-based nuclear medicine department
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with hypercalcemia and elevated parathyroid hormone (PTH) presents for localization of suspected parathyroid adenoma prior to surgical consultation. The patient is referred from endocrinology after biochemical confirmation of primary hyperparathyroidism and intermittent neck ultrasound that is inconclusive. The nuclear medicine team administers two small doses of different radiopharmaceuticals (commonly sestamibi and pertechnetate or a dual-phase dual-tracer technique), acquires images at appropriate time points, performs image normalization and comparison, and may perform digital subtraction to highlight focal increased radiotracer uptake in a parathyroid gland. Images and a written report are provided to the referring surgeon and endocrinologist for preoperative planning. Typical workflow includes patient intake and consent, tracer administration, timed imaging acquisition, image processing/subtraction, and interpretation by a board-certified nuclear medicine physician. Typical site of service is an outpatient imaging center, hospital nuclear medicine department, or ambulatory surgical center when used for preoperative localization. Typical service type is diagnostic nuclear medicine imaging with image post-processing and interpretation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation portion separate from technical imaging. |